Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy-Reference-Cited by-同舟云学术

Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy

Published:2021-06 Issue: Volume:333 Page:127-132
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Veselka Josef,Faber Lothar,Liebregts Max,Cooper Robert,Januska Jaroslav,Kashtanov Maksim,Dabrowski Maciej,Hansen Peter Riis,Seggewiss Hubert,Bonaventura Jiri,Polakova Eva,Hansvenclova Eva,Bundgaard Henning,ten Berg Jurriën,Stables Rodney Hilton,Jarkovsky Jiri,Jensen Morten Kvistholm

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Non-surgical myocardial reduction of hypertrophic obstructive cardiomyopathy;Sigwart;Lancet.,1995

2. Septal reduction therapy for hypertrophic obstructive cardiomyopathy;Fifer;J. Am. Coll. Cardiol.,2018

3. Historical perspectives in the evolution of hypertrophic cardiomyopathy;Panza;Cardiol. Clin.,2019

4. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy;Sorajja;J. Am. Coll. Cardiol.,2017

5. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy;Elliott;Eur. Heart J.,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy;Journal of Clinical Medicine;2023-10-19

2. Looking Back at 30 Years of Alcohol Septal Ablation and Looking Forward to the Future;Canadian Journal of Cardiology;2023-09

3. A Narrative Review of Emerging Therapies for Hypertrophic Obstructive Cardiomyopathy;Current Cardiology Reviews;2023-07

4. Predictors of cardiovascular implantable electronic device dependence at long-term follow-up after alcohol septal ablation in hypertrophic cardiomyopathy patients;Journal of Interventional Cardiac Electrophysiology;2023-04-12

5. A novel risk model to predict all-cause mortality in patients undergoing percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy;Cardiology Plus;2022-10